Pfizer Inc. elected COO Albert Bourla to its board, effective Feb. 23.
Prior to his appointment as COO, Bourla was the group president of Pfizer Innovative Health.
Pfizer adds COO to board
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Pfizer Inc. elected COO Albert Bourla to its board, effective Feb. 23.
Prior to his appointment as COO, Bourla was the group president of Pfizer Innovative Health.